StockWatch
·
Pharmaceuticals
Quarterly Result12 May 2026, 02:07 pm

Novartis India Approves Audited FY26 Results

AI Summary

Novartis India Ltd's Board of Directors approved the audited financial results for the quarter and financial year ended March 31, 2026, in a meeting held on May 12, 2026. The meeting, which commenced at 11:30 A.M. (IST) and concluded at 01:50 P.M. (IST), also took on record the Audit Report dated May 12, 2026, issued by the Statutory Auditors. The audited financial results and related documents are available on the company's website.

Key Highlights

  • Audited financial results for FY26 approved by the Board on May 12, 2026.
  • Revenue from Operations for FY26 is ₹2,105.8 million.
  • Profit for the Year ended March 31, 2026, stands at ₹931.8 million.
  • Earnings Per Share (Basic & Diluted) is ₹10.23.